BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 30033380)

  • 1. 3D printed medicines: A new branch of digital healthcare.
    Awad A; Trenfield SJ; Gaisford S; Basit AW
    Int J Pharm; 2018 Sep; 548(1):586-596. PubMed ID: 30033380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low temperature fused deposition modeling (FDM) 3D printing of thermolabile drugs.
    Kollamaram G; Croker DM; Walker GM; Goyanes A; Basit AW; Gaisford S
    Int J Pharm; 2018 Jul; 545(1-2):144-152. PubMed ID: 29705104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3D scanning and 3D printing as innovative technologies for fabricating personalized topical drug delivery systems.
    Goyanes A; Det-Amornrat U; Wang J; Basit AW; Gaisford S
    J Control Release; 2016 Jul; 234():41-8. PubMed ID: 27189134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of Fused Deposition Modelling (FDM) Method of 3D Printing in Drug Delivery.
    Long J; Gholizadeh H; Lu J; Bunt C; Seyfoddin A
    Curr Pharm Des; 2017; 23(3):433-439. PubMed ID: 27784251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3D Printing Pharmaceuticals: Drug Development to Frontline Care.
    Trenfield SJ; Awad A; Goyanes A; Gaisford S; Basit AW
    Trends Pharmacol Sci; 2018 May; 39(5):440-451. PubMed ID: 29534837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. M3DISEEN: A novel machine learning approach for predicting the 3D printability of medicines.
    Elbadawi M; Muñiz Castro B; Gavins FKH; Ong JJ; Gaisford S; Pérez G; Basit AW; Cabalar P; Goyanes A
    Int J Pharm; 2020 Nov; 590():119837. PubMed ID: 32961295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3D Printing Technology in Customized Drug Delivery System: Current State of the Art, Prospective and the Challenges.
    Khan FA; Narasimhan K; Swathi CSV; Mustak S; Mustafa G; Ahmad MZ; Akhter S
    Curr Pharm Des; 2018; 24(42):5049-5061. PubMed ID: 30636582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advancing non-destructive analysis of 3D printed medicines.
    Jørgensen AK; Ong JJ; Parhizkar M; Goyanes A; Basit AW
    Trends Pharmacol Sci; 2023 Jun; 44(6):379-393. PubMed ID: 37100732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3D printing in personalized drug delivery: An overview of hot-melt extrusion-based fused deposition modeling.
    Dumpa N; Butreddy A; Wang H; Komanduri N; Bandari S; Repka MA
    Int J Pharm; 2021 May; 600():120501. PubMed ID: 33746011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3D Printing Methods for Pharmaceutical Manufacturing: Opportunity and Challenges.
    Warsi MH; Yusuf M; Al Robaian M; Khan M; Muheem A; Khan S
    Curr Pharm Des; 2018; 24(42):4949-4956. PubMed ID: 30520367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Overview of 3D Printing Technologies for Soft Materials and Potential Opportunities for Lipid-based Drug Delivery Systems.
    Vithani K; Goyanes A; Jannin V; Basit AW; Gaisford S; Boyd BJ
    Pharm Res; 2018 Nov; 36(1):4. PubMed ID: 30406349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient acceptability of 3D printed medicines.
    Goyanes A; Scarpa M; Kamlow M; Gaisford S; Basit AW; Orlu M
    Int J Pharm; 2017 Sep; 530(1-2):71-78. PubMed ID: 28750894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Graphical Review on the Escalation of Fused Deposition Modeling (FDM) 3D Printing in the Pharmaceutical Field.
    Melocchi A; Uboldi M; Cerea M; Foppoli A; Maroni A; Moutaharrik S; Palugan L; Zema L; Gazzaniga A
    J Pharm Sci; 2020 Oct; 109(10):2943-2957. PubMed ID: 32679215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced Pharmaceutical Applications of Hot-Melt Extrusion Coupled with Fused Deposition Modelling (FDM) 3D Printing for Personalised Drug Delivery.
    Tan DK; Maniruzzaman M; Nokhodchi A
    Pharmaceutics; 2018 Oct; 10(4):. PubMed ID: 30356002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of fused deposition modeling 3D printers for pharmaceutical and medical applications.
    Feuerbach T; Kock S; Thommes M
    Pharm Dev Technol; 2018 Dec; 23(10):1136-1145. PubMed ID: 29938558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disrupting 3D printing of medicines with machine learning.
    Elbadawi M; McCoubrey LE; Gavins FKH; Ong JJ; Goyanes A; Gaisford S; Basit AW
    Trends Pharmacol Sci; 2021 Sep; 42(9):745-757. PubMed ID: 34238624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3D printed drug delivery devices: perspectives and technical challenges.
    Palo M; Holländer J; Suominen J; Yliruusi J; Sandler N
    Expert Rev Med Devices; 2017 Sep; 14(9):685-696. PubMed ID: 28774216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D Printing Technology in Design of Pharmaceutical Products.
    Ameeduzzafar ; Alruwaili NK; Rizwanullah M; Abbas Bukhari SN; Amir M; Ahmed MM; Fazil M
    Curr Pharm Des; 2018; 24(42):5009-5018. PubMed ID: 30652636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Track-and-trace: Novel anti-counterfeit measures for 3D printed personalized drug products using smart material inks.
    Trenfield SJ; Xian Tan H; Awad A; Buanz A; Gaisford S; Basit AW; Goyanes A
    Int J Pharm; 2019 Aug; 567():118443. PubMed ID: 31212052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDM 3D printing of modified drug-delivery systems using hot melt extrusion: a new approach for individualized therapy.
    Cunha-Filho M; Araújo MR; Gelfuso GM; Gratieri T
    Ther Deliv; 2017 Nov; 8(11):957-966. PubMed ID: 29061104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.